Posts

Starkes Jahresergebnis: Novartis steigert den Nettoumsatz um 10%, das operative Kernergebnis um 18% (kWk¹) sowie die Margen. Weitere Innovationsdynamik mit mehreren positiven Phase-3-Ergebnissen

Starkes Jahresergebnis: Novartis steigert den Nettoumsatz um 10%, das operative Kernergebnis um 18% (kWk¹) sowie die Margen. Weitere Innovationsdynamik mit mehreren positiven Phase-3-Ergebnissen
arcticnovartis

Ad-hoc-Mitteilung gemäss Art. 53 KR 

Geschäftsjahr (fortzuführende Geschäftsbereiche2)

Novartis delivers strong full year performance, 10% net sales and 18% core operating income growth (cc¹), with margin expansion. Continuing innovation momentum with multiple positive Ph3 readouts

Novartis delivers strong full year performance, 10% net sales and 18% core operating income growth (cc¹), with margin expansion. Continuing innovation momentum with multiple positive Ph3 readouts
arcticnovartis

Ad hoc announcement pursuant to Art. 53 LR

Full year (continuing operations2)

In Colombia, a researcher works against a devastating disease

In Colombia, a researcher works against a devastating disease
tavasat1

Going upstream to improve heart health in Philadelphia

Going upstream to improve heart health in Philadelphia
mihai_novartis

A cancer patient gets a new lease on life

A cancer patient gets a new lease on life
tavasat1

A cancer patient gets a new lease on life

A cancer patient gets a new lease on life
tavasat1

Empowering the next generation of healthcare leaders

Empowering the next generation of healthcare leaders
attila_novartis

Empowering the next generation of healthcare leaders

Empowering the next generation of healthcare leaders
attila_novartis

Giving voice to people with a misunderstood disease

Giving voice to people with a misunderstood disease
mihai_novartis

Giving voice to people with a misunderstood disease

Giving voice to people with a misunderstood disease
mihai_novartis